AbbVie Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	61,160	56,334	54,318	58,054	56,197
Revenue Growth (YoY)	8.57%	3.71%	-6.44%	3.30%	22.69%
Cost of Revenue	17,342	16,689	16,726	16,527	17,314
Gross Profit	43,818	39,645	37,592	41,527	38,883
Selling, General & Admin	13,838	13,189	12,904	14,584	11,872
Research & Development	9,007	8,131	7,038	6,487	6,820
Other Operating Expenses	-241	-7	-10	228	432
Operating Expenses	22,604	21,313	19,932	21,299	19,124
Operating Income	21,214	18,332	17,660	20,228	19,759
Interest Expense	-2,627	-2,808	-2,224	-2,230	-2,423
Interest & Investment Income	-	648	540	186	39
Currency Exchange Gain (Loss)	-58	-21	-146	-148	-51
Other Non Operating Income (Expenses)	702	271	190	142	55
EBT Excluding Unusual Items	19,231	16,422	16,020	18,178	17,379
Merger & Restructuring Charges	-276	-792	-119	-539	-587
Gain (Loss) on Sale of Assets	-	-	-	172	-
Asset Writedown	-847	-4,476	-4,230	-876	-
Legal Settlements	-	-910	485	-	-
Other Unusual Items	-6,495	-3,771	-5,128	-2,761	-2,679
Pretax Income	6,597	3,716	6,250	13,477	12,989
Income Tax Expense	2,364	-570	1,377	1,632	1,440
Earnings From Continuing Operations	4,233	4,286	4,873	11,845	11,549
Minority Interest in Earnings	-7	-8	-10	-9	-7
Net Income	4,226	4,278	4,863	11,836	11,542
Preferred Dividends & Other Adjustments	-	40	43	54	74
Net Income to Common	4,226	4,238	4,820	11,782	11,468
Net Income Growth	-1.22%	-12.03%	-58.91%	2.55%	150.04%
Shares Outstanding (Basic)	1,773	1,769	1,768	1,771	1,770
Shares Outstanding (Diluted)	1,773	1,773	1,773	1,778	1,777
Shares Change (YoY)	-	-	-0.28%	0.06%	6.22%
EPS (Basic)	2.38	2.40	2.73	6.65	6.48
EPS (Diluted)	2.36	2.39	2.72	6.63	6.45
EPS Growth	-1.26%	-12.13%	-58.97%	2.79%	137.13%
Free Cash Flow	-	17,832	22,062	24,248	21,990
Free Cash Flow Per Share	-	10.06	12.44	13.64	12.38
Dividend Per Share	6.650	6.290	5.990	5.710	5.310
Dividend Growth	5.72%	5.01%	4.90%	7.53%	9.71%
Gross Margin	71.65%	70.38%	69.21%	71.53%	69.19%
Operating Margin	34.69%	32.54%	32.51%	34.84%	35.16%
Profit Margin	6.91%	7.52%	8.87%	20.29%	20.41%
Free Cash Flow Margin	-	31.65%	40.62%	41.77%	39.13%
EBITDA	29,417	26,718	26,358	28,695	28,280
EBITDA Margin	48.10%	47.43%	48.52%	49.43%	50.32%
D&A For EBITDA	8,203	8,386	8,698	8,467	8,521
EBIT	21,214	18,332	17,660	20,228	19,759
EBIT Margin	34.69%	32.54%	32.51%	34.84%	35.16%
Effective Tax Rate	35.83%	-	22.03%	12.11%	11.09%
Advertising Expenses	-	2,100	2,200	2,000	2,100

Updated Feb 4, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q